2011
The ‘preclinical’ phase of Alzheimer’s disease is a future target for treatment, but additional research is essential to understand the (…)
Consulter 
2011
To assess the diagnostic potential of imaging striatal monoaminergic terminal integrity with the vesicular monoamine transporter type 2 (VMAT2) radioligand (…)
Consulter
2011
To provide guidance regarding the most appropriate voxel-based morphometry (VBM)-derived method for assessing hippocampal atrophy in early Alzheimer’s disease (AD).
Consulter
2011
In the past decade, a "default mode network" (DMN) has been highlighted in neuroimaging studies as a set of brain (…)
Consulter
2012
The hippocampus is affected at an early stage in the development of Alzheimer’s disease (AD). With the use of structural (…)
Consulter
2012
Identifying the specific substrates of memory deficits in early Alzheimer’s disease would help to develop clinically-relevant therapies. The present study (…)
Consulter
